Patent Assignment
Reel/Frame 025640/0983
Assignment of Assignor's Interest
Recorded: 2011-01-14
Pages: 3
Assignee
SEATTLE GENETICS, INC.
21823 30TH DRIVE SE, BOTHELL, WASHINGTON, 98021
Covered Properties
(2)
Post-Relapse Treatment of CD30 Expressing Lymphomas
Patent:
8,758,758 →
Application:
12/985,687 →
Post-Relapse Treatment of CD30 Expressing Lymphomas
Application:
61/293,311 →
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.